Kinases in diabetes. Part II. 11-12 November 2004, Manchester, UK.
Zierath
Juleen R
JR
Karolinska Institute, Department of Clinical Physiology, Karolinska Hospital, SE-171 77 Stockholm, Sweden. Juleen.Zierath@fyfa.ki.se
D000818:Animals; D001709:Biotechnology / Q000639:trends; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000201:enzymology*; D004345:Drug Industry / Q000639:trends; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D010770:Phosphotransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006113:United Kingdom
D004791:Enzyme Inhibitors; D007328:Insulin; D010770:Phosphotransferases